Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Alberto Ortíz

ResearcherPublications, citations & collaboration network

Alberto Ortíz is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,492 works, 215,030 citations, an h-index of 128 and an i10-index of 805.

1,492
Works
215,030
Citations
128
h-index
805
i10-index

How has Alberto Ortíz's publication output changed over time?

ScholarIQpublication output · 2014–2024

Output grew0% over the shown period — from 1 works in 2014 to 1 in 2024.

1
1
1
2
2
1
3
1
20142015201620172018201920202024

What are the most-cited papers on Alberto Ortíz?

ScholarIQmost cited works
Chronic kidney disease and the global public health agenda: an international consensus
Anna Francis, Meera N. Harhay, Albert Ong, Sri Lekha Tummalapalli, Alberto Ortíz, Agnes B. Fogo, Danilo Fliser, Prabir Roy‐Chaudhury, Monica Fontana, Masaomi Nangaku, Christoph Wanner, Charu Malik, Anne Hradsky, Dwomoa Adu, Sunita Bavanandan, Ana María Cusumano, Laura Solá, Ifeoma Ulasi, Vivekanand Jha, American Society of Nephrology, International Society of Nephrology
Nature Reviews Nephrology. 20241,212 CitationsOPEN ACCESS
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortíz, Dominique P. Germain, Robert J. Desnick, Juan Politei, Michael Mauer, Alessandro P. Burlina, Christine M. Eng, Robert J. Hopkin, Dawn A. Laney, Aleš Linhart, Stephen Waldek, Eric Wallace, Frank Weidemann, William R. Wilcox
S42433034. 2018651 CitationsOPEN ACCESS
The systemic nature of CKD
Carmine Zoccali, Raymond Vanholder, Ziad A. Massy, Alberto Ortíz, Pantelis Sarafidis, Friedo W. Dekker, Danilo Fliser, Denis Fouque, Gunnar H. Heine, Kitty J. Jager, Mehmet Kanbay, Francesca Mallamaci, Gianfranco Parati, Patrick Rossignol, Andrzej Wiecek, Gerard London
Nature Reviews Nephrology. 2017441 CitationsOPEN ACCESS
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Alberto Ortíz, Adrian Covic, Danilo Fliser, Denis Fouque, David Goldsmith, Mehmet Kanbay, Francesca Mallamaci, Ziad A. Massy, Patrick Rossignol, R. Vanholder, Andrzej Więcek, Carmine Zoccali, Gérard M. London
The Lancet. 2014435 Citations
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Alberto Ortíz, Mario Cozzolino, Danilo Fliser, Denis Fouque, Dimitrios Goumenos, Ziad A. Massy, Alexander R. Rosenkranz, Ivan Rychlík, María José Soler, Kate Stevens, Roser Torrá, Serhan Tuğlular, Christoph Wanner, Ron T. Gansevoort, ERACODA Working Group, Raphaël Duivenvoorden, Casper Franssen, Marc H. Hemmelder, Luuk B. Hilbrands, Kitty J. Jager, Marlies Noordzij, Priya Vart, Ron T Gansevoort
Nephrology Dialysis Transplantation. 2020378 CitationsOPEN ACCESS

Related on ScholarIQ

Universidad de Cádiz
Institution
Chronic kidney disease and the global public health agenda: an international consensus
Paper
Fabry disease revisited: Management and treatment recommendations for adult patients
Paper
The systemic nature of CKD
Paper
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Paper
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Paper
470M+ articles · free account